Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada.
Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8L6, Canada.
Int J Mol Sci. 2021 Mar 13;22(6):2911. doi: 10.3390/ijms22062911.
Metastasis to the bone is a common feature of many cancers including those of the breast, prostate, lung, thyroid and kidney. Once tumors metastasize to the bone, they are essentially incurable. Bone metastasis is a complex process involving not only intravasation of tumor cells from the primary tumor into circulation, but extravasation from circulation into the bone where they meet an environment that is generally suppressive of their growth. The bone microenvironment can inhibit the growth of disseminated tumor cells (DTC) by inducing dormancy of the DTC directly and later on following formation of a micrometastatic tumour mass by inhibiting metastatic processes including angiogenesis, bone remodeling and immunosuppressive cell functions. In this review we will highlight some of the mechanisms mediating DTC dormancy and the complex relationships which occur between tumor cells and bone resident cells in the bone metastatic microenvironment. These inter-cellular interactions may be important targets to consider for development of novel effective therapies for the prevention or treatment of bone metastases.
肿瘤转移至骨骼是许多癌症的常见特征,包括乳腺癌、前列腺癌、肺癌、甲状腺癌和肾癌。一旦肿瘤转移至骨骼,它们基本上是无法治愈的。骨骼转移是一个复杂的过程,不仅涉及肿瘤细胞从原发肿瘤进入循环系统的血管内渗出现象,还涉及循环系统中的肿瘤细胞从血管外渗至骨骼,在骨骼中,它们遇到的环境通常会抑制肿瘤的生长。骨骼微环境可以通过直接诱导播散性肿瘤细胞(DTC)休眠,以及在形成微转移瘤块后通过抑制包括血管生成、骨骼重塑和免疫抑制细胞功能等转移过程,来抑制 DTC 的生长。在这篇综述中,我们将重点介绍一些介导 DTC 休眠的机制,以及肿瘤细胞与骨骼驻留细胞在骨骼转移微环境中的复杂关系。这些细胞间相互作用可能是开发预防或治疗骨骼转移的新型有效疗法的重要考虑因素。